A clinical Study to Evaluate the Role of Herbal Immunomodulators as add on Treatment in Asymptomatic and Mildly Symptomatic COVID-19 Confirmed Cases.

Sri Sri Tattva0 个研究点目标入组 40 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Confirmed Asymptomatic and mildly symptomatic cases of COVID-19 infection by laboratory tests
•Age limit 18 to 60 years both Male and Female
•Uncomplicated cases of COVID - 19 patients on Allopathic medication
•Patients in whom ventilator support is not required
•Patients with no associated co morbidities
•Patients willing to give informed consent to participate in the clinical trial

•COVID-19 positive patients above 60 years of age & below 18 years with Symptoms.
•Patients with associated comorbidities like hypertension, type 2 or type 1 diabetes mellitus, chronic or acute renal failure
•Patients on Immuno-suppression therapy
•Pregnant Women or lactating mothers Patients in advanced stage of disease requiring emergency medical intervention like pneumonia, bronchial asthma, organ failure

发起方